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P0011 EVALUATION OF BONE MARROW DERIVED MESENCHYMAL
STEM CELLS INJECTION IN EGYPTIAN PATIENTS WITH LIVER
CIRRHOSIS
M.A. Amin1, S.A. Emad2, A.M. El-Mahdy2, D.A. Sabri3, Y.A. Yossief2. 1Internal
Medicine, Cairo University, Cairo, 2General Surgury, Al-azhar University, Cairo,
3Biochemistry, Cairo University, Cairo, Egypt
E-mail Address: monasleman@hotmail.com
INTRODUCTION: Liver transplantation has become a procedure with a relatively
good 5-year survival. Yet, organ donation has not kept up with the demand because
of many problems, including relative lack of donors, operative complication, risk of
rejection and high cost. Owing to the ability of stem cells to repopulate and differentiate
at the engrafted site, stem cell-based therapy has received attention as a possible
alternative to organ transplantation.
AIMS & METHODS: was to evaluate the effect of transplantation of autologous
bone marrow derived mesenchymal stem cells into cirrhotic patients in improving
liver function tests as a possible alternative to organ transplantation
Patients and methods: After approval of ethical committee, twenty patients with end
stage liver cirrhosis were selected from the outpatients of internal medicine department
in Kaser Al-Aini hospitals. 30−40 ml bone marrow was aspirated from iliac crest
under complete aseptic condition and after local anesthesia. Human BM-derived MSCs
were Isolated, propagated, and identified. Under complete aseptic conditions, a mean
of 10×106 of the isolated DM–derived MSCs in 5 ml normal saline were injected
intrasplenic to the patients under sonographic guidance, and without anesthesia, as
one sitting.
Monthly Follow up for 6 months by clinical assessment and laboratory investigations
including serum total bilirubin, serum albumin, aspartate amino transferase, alanine
amino transferase, prothrombin time, prothrombin concentration, INR, and abdominal
ultrasonography were done.
RESULTS: Statistical comparison between the clinical and laboratory data before
and 6 months after MSCs injections showed a highly significant decrease in the
main total bilirubin level from 2.55±1.11 to 1.91±1.0 (P value <0.01), a significant
increase in the main albumin level from 2.83±0.44 to 3.26±0.33 (P value <0.05),
a highly significant decrease in the mean AST from 78.00±25.35 to 43.50±18.74
(P value <0.01) a highly significant decrease in the mean ALT from 50.50±11.26
to 36.83±10.78 (P value <0.01), a significant decrease in the mean prothrombin
time from 18.44±2.0 to 18.00±2.68 (P value <0.05), a significant increase in the
mean prothrombin concentration from 47.05±11.47 to 57.25±14.47 (P value <0.05),
a significant decrease in the mean INR from 1.71±0.26 to 1.65±0.38 (P value <0.05)
CONCLUSION: Our study suggested the safety, feasibility and efficacy of the
intrasplenic injection of autologous bone marrow-derived mesenchymal stem cells in
improving liver functions in cirrhotic patients
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P0012 DEPRESSION AND ANXIETY IN PATIENTS WITH CHRONIC
LIVER DISEASE
D.D. Popovic1, N. Kovacevic1,2, T. Alempijevic1,2, M. Spuran1, S. Djuranovic1,2,
M. Krstic1,2. 1Clinic for Gastroenterology, Clinical centre of Serbia, 2Medical
School, University of Belgrade, Belgrade, Serbia
E-mail Address: pduschan@gmail.com
INTRODUCTION: In previous years mental health of the patients including those
with chronic liver disease (CLD) raze interest because their presence leads to reduced
quality of life and it is associated worsening of clinical evolution, reduced compliance
and increased mortality. The most frequently described are depression and anxiety. The
aim of our study was to describe depression and anxiety in patients with CLD, and
assessment impact of socio-demographic characteristics, etiology and disease severity
and on the occurrence of these disorders.
AIMS & METHODS: We performed a cross sectional study. Disease‘s severity was
determined by the Child-Pough classification. Assessment of depression and anxiety
were performed by Hamilton depression rating scale (HDRS) and Hamilton anxiety
rating scale (HARS). Clinically significant depression was marked for the value of
HDRS >10. Clinically significant anxiety was marked for the value of HARS >17.
For statistical analyzes we used Kolmogorov-Smirnov test, one-way ANOVA and post-
hoc Turkey’s test. Statistical significance was set for p< 0.05.
RESULTS: We include 54 male and 43 female patients, mean age 53.5±12.8 yrs.
The average value of the HDRS score was 13.4±9.4 The average value of the
HARS score was 10.0±6.4. Depression was present in 55.7%, and anxiety in 13.4%
patients. Men had significantly lower HARS score than women (8.6±6.0 vs. 11.5±6.7)
(t = 2.332, p = 0.022). Patients with different employment status were significantly
different in the HDRS (F= 3.652, p = 0.029) and HARS scores (F= 3.998, p = 0.021).
In comparison with patients who are retired, employed patients had significantly lower
HDRS (10.5±8.9 vs. 15.8±9.2) and HARS scores (7.5±5.0 vs. 11.6±6.9). There were
no significant differences in HDRS scores of patients with different: gender (p = 0.107),
age (p = 0.119), level of education (p = 0.730), occupation (p = 0.807), marital status
(p = 0.054), children status (p = 0.189), alcohol consumption (p = 0.380), smoking
status (p = 0.619), etiology (p = 0.209) and severity of CLD (p = 0.662). Patients with
different: age (p = 0.128), marital status (p = 0.187), level of education (p = 0.848),
occupation (p = 0.465), children status (p = 0.175), alcohol consumption (p = 0.075),
smoking status (p = 0.824), etiology (p = 0.074) and severity of CLD (p = 0.772) did
not differ in the HARS scores.
CONCLUSION: Men have lower anxiety scores than women. Patients who are
employed have lower scores of depression and anxiety in relation to the retired. For
the other socio-demographic characteristics, etiology and severity of CLD, there was
no difference in scores of depression and anxiety.
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P0013 ASSESMENT OF ADRENAL FUNCTION IN HCV PATIENTS WITH
LIVER CIRRHOSIS AFTER VARICEAL BLEEDING
R.A. Hafez1, M.M. Abdelaal2, O.M. Basha3, M.H. Moraad4, M.A. Ashour3,
M.A. Sabry3. 1Medical Microbiology and Immunology, Faculty of Medicine, Zagazig
University, Egypt, 2Internal Medicine, Faculty of Medicine, Zagazig University
(President of the university), 3Internal Medicine, Faculty of Medicine, 4Clinical and
Chemical Pathology, Zagazig University, Zagazig, Egypt
E-mail Address: Raghdahafez@gmail.com
INTRODUCTION: Patients with liver cirrhosis commonly have abnormalities in
adrenal function. Adrenal insufficiency is common in critically ill patients with liver
cirrhosis, these abnormalities have been described in the absence of clinical sepsis
raising the possibility that the adrenal insufficiency arising in liver cirrhosis may be a
different entity to that observed in septic shock.
AIMS & METHODS: The aim of this study is to assess adrenal function in cirrhotic
patients after variceal bleeding and if there is relationship between the severity of liver
disease and adrenal insufficiency.it included 60 hepatic patients (30 wih history of
bleeding and 30 non bleeder)basal and subsequent cortisol levela were measured.
RESULTS: Our results showed a clear relationship between the severity of liver disease
and adrenal insufficiency as follow: The serum basal cortisol level “sample I” in child
A was normal in both groups wether none bleeders or bleeders.
– The serum basal cortisol level “sample I” in child B was subnormal in 20% of
group without bleeding and 10% of group with bleeding, and in child C it was also
subnormal in 60% of group without bleeding and 30% of group with bleeding,
– The response to synecthen injection (LDSST) was relatively good in all groups
without bleeding (A, B and C) and all groups with bleeding, and the maximum
cortisol response was after one hour from synecthen injection, but inspite of these
results, the response was much lower in group C than group B than group A
respectively in all groups none bleeders and bleeders. The responses to synecthen
injection (LDSST) were significantly low in groups with bleeding than those groups
without bleeding.
CONCLUSION: It is concluded from this study that; Adrenal dysfunction is com-
mon in patients with advanced liver cirrhosis. Adrenal insufficiency is progressively
increased with worsening severity of liver disease described by modified Child-Pugh
classification. Adrenal insufficiency was found many frequently in cirrhotic patients
during variceal bleeding. Morning basal cortisol could be useful to identify cirrhotics
with high risk of adrenal insufficiency.
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P0014 THE INHIBITORY EFFECT OF NUCLEAR RECEPTORS LIGANDS
ON HEPATIC STELLATE CELLS (HSC) ACTIVATION AND PROLIFERATION
IS MEDIATED BY DOWNREGULATION OF CELL CYCLE PROTEINS
R. Bruck1, S. Reif2, S. Abramovitch1, E. Sharvit1. 1Gastroenterology and Liver
Diseases, 2Pediatrics, Tel Aviv Sourasky Medical Center, Tel Aviv, Israel
E-mail Address: rafib@tasmc.health.gov.il
INTRODUCTION: Peroxisome proliferator activator receptors (PPAR) ligands have
been shown to inhibit development of liver fibrosis.
AIMS & METHODS: In this study, we investigated the effects of the combination
of ligands of peroxisome proliferator activator receptor g (PPARg) and retinoic acid
receptor (ATRA, 9-cis and PPARg ligand 15-deoxy-D12,14-prostaglandinJ(2)[PJ(2)])
on activation and proliferation of primary hepatic stellate cells, and on PPARg, aSMA
gene and protein expression in these cells. We also determined the effects of the
combination of ligands on cell cycle proteins involved in HSC proliferation.
Methods: We assessed proliferation of primary hepatic stellate cells by BrdU and
crystal violet. Cell cycle was determined by FACS analysis. Cyclin D1, P21, P27,
mTOR, p70S6K . Collagen Ia1, and aSMA proteins were determined by western blot
analysis. Collagen Ia1, and aSMAmRNA expression were determined by real time
PCR.
RESULTS: Proliferation of primary HSC was inhibited by the combination of 9-Cis,
ATRA and PJ and the effect of the 3 ligands was additive. As demonstrated by FACS
analysis, the inhibition of proliferation was due to cell cycle arrest. Studies using
western blot analysis demonstrated reduced expression of cyclin D1 and increased
expression of P21 and P27 by the above combination. When examining proteins leading
to HSC proliferation, we found that the 3 ligands down regulated the phosphorylation
of mTOR and p70S6K . Using Oil red-O staining, we demonstrated that the combined
treatment led to inhibition of release of vitamin A droplets from cultured HSC. Studies
using real time PCR and western blot analysis showed marked inhibition of collagen
Ia1 and aSMA in the presence of the combination of the 3 ligands.
CONCLUSION: Our studies demonstrate that the combination of these 3 ligands
inhibited the mTOR pathway which leads to inhibition of HSC proliferation, G0/G1
arrest and affect cell cycle proteins. Furthermore, the inhibition of collagen Ia1 and
aSMA by the 3 ligands combination indicates an antifibrotic effect.
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P0015 BREATH ANALYSIS BY PROTON TRANSFER REACTION TIME
OF FLIGHT MASS SPECTROMETRY IN CIRRHOTIC PATIENTS
F. Morisco1,2, E. Aprea3, V. Lembo2, V. Fogliano1, P. Vitaglione1, G. Mazzone2,
L. Cappellin3, F. Gasperi3, N. Caporaso2, F. Biasioli3. 1Department of Food
Science, University of Naples Federico II, Portici (NA), 2Department of Clinical and
Experimental Medicine, University of Naples Federico II, Napoli, 3Food Quality and
Nutrition Department, IASMA Research and Innovation Centre, Fondazione Edmund
Mach, S. Michele a/A, Italy
E-mail Address: v.lembo@hotmail.it
INTRODUCTION: Being rapid and non-invasive, breath analysis is a promising
diagnostic tool although difficulties related to data interpretation, reproducibility and
sensibility have limited its application.
AIMS & METHODS: The aim of the present work was to investigate whether
a recently realized direct injection mass spectrometric technique (Proton Transfer
Reaction Time of Flight Mass Spectrometry, PTR-ToF-MS) allows the direct and
noninvasive diagnosis of cirrhosis as well as the assessment of the disease severity by
direct analysis of exhaled breath.
Twelve patients (M/F 8/4, mean age 70.5, range 42−80 years) with liver cirrhosis of
different etiologies and status and 14 healthy subjects (M/F 5/9, mean age 52.3, range
35−77 years) were enrolled in the study. The etiology of cirrhosis was viral in 9 (8
HCV and 1 HBV) and metabolic in 3. The Child-Pugh class was A in 6 patients, B
in 3, and C in the remaining 3 patients.
Real time breath analysis was performed using a buffered end-tidal on-line sampler
directly coupled to a PTR-ToF-MS. Spectra were acquired using the data acquisition
software TOF-DAQ (Tofwerk AG, Switzerland) with a mass/charge range of 10–400
Th. The data were analyzed by non-parametric ANOVA (Kruskal-Wallis test) using
the Statistica 9.1 (StatSoft, USA) software.
RESULTS: Eight peaks resulted significantly different in cirrhotic patients compared
to healthy controls: two related to ketones, (2-pentanone, C8-ketone), two to terpenes
and four to sulfur compounds. Three peaks resulted significantly different between
Child-Pugh A cirrhotic patients and Child-Pugh B+C cirrhotic patients and precisely:
C8-ketone, a monoterpene and a NS-compound.
CONCLUSION: In conclusion: real time analysis of breath allows to distinguish
cirrhotic from healthy subjects and well compensated liver disease from more advanced
A108 UEG Week 2012 Poster Presentations
liver stage. The proposed method can be used to identify the stage and severity of
liver disease in real time with a safe and non-invasive procedure.
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P0016 RANDOMIZED CONTROLLED TRIAL COMPARING EFFECTS
OF SEDATION FOR UPPER GASTROINTESTINAL ENDOSCOPY WITH
PROPOFOL VERSUS MIDAZOLAM ON PSYCHOMETRIC TESTS AND
CRITICAL FLICKER FREQUENCY IN CIRRHOTICS
A. Agrawal1, B. Sharma1, P. Sharma1, R. Uppal2, S. Sarin1. 1Gastroenterology,
2Anaesthesia, G B Pant Hospital, New Delhi, India
E-mail Address: amit_04_dr@yahoo.com
INTRODUCTION: Patients with cirrhosis are at increased risk of development of
complicationsrelated to sedation
AIMS & METHODS: To compare effects of sedation for upper gastrointestinal
endoscopy (UGIE) with propofol and midazolam on psychometric tests and critical
flicker frequency (CFF) in cirrhotics.
Design: Prospective randomized study.
Setting: A tertiary-referral university hospital endoscopy unit.
Patients and methods: 148 cirrhotic patients randomized into 3 groups, propofol group
(n = 47), midazolam group(n = 49) and no sedation (n = 52). All patients underwent CFF
test and combination of psychometry [number connection test-A and B(NCT-A,B);
digit symbol test(DST), line tracing test(LTT) and serial dotting test(SDT) at baseline
and at 2 hours post endoscopy. CFF done at 30 min and repeated every 30 mins for
2 hours.
Main outcome measurements: Deterioration in psychometry tests and CF
RESULTS: 92/148 patients(62.2%) had minimal hepatic encephalopathy(MHE) before
the endoscopy. In propofol group there was no significant deterioration in psychom-
etry [NCT-A(55.6±18.7 vs 56.4±19.0 sec), NCT-B(98.2±35.1 vs 97.8±34.6 sec),
DST(26.7±5.7 vs 26.3±5.3), LTT(112.9±35.7 vs 113.7±36.6 sec), SDT (94.6±34.1
vs 95.2±34.5 sec)]. Significant deterioration from baseline (39.8±2.9Hz) was seen
in CFF at 30 min (38.8±2.3 Hz) and 1 hr (39.2±2.4 Hz), p = 0.01 but no difference
thereafter. In midazolam group significant deterioration was observed on psychometry
[NCT-A (56.0±18.5 vs 60.4±19.8 sec), NCT-B(99.9±29.1 vs 105.9.6±30.3 sec),
DST(26.1±4.7 vs25.2±4.3), LTT(129.1±34.5 vs132.9±35.4sec), SDT (95.6±34.2
vs midazolam group showed overt HE after sedation. No deterioration observed in
psychometry and CFF in cirrhotics without sedation.
CONCLUSION: Propofol sedation for UGIE is associated with earlier recovery
in patients with cirrhosis compared to midazolam which causes deterioration of
psychometric tests and CFF for a longer time in comparison with propofol
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P0017 MELD SCORE AND CTP SCORE IN THE PREDICTION
OF SURVIVAL OF PATIENTS WITH CIRRHOSIS AWAITING LIVER
TRANSPLANTATION
A. Krishnan1, J. Venkataraman1. 1Department of Gastroenterology and Liver
transplantation unit, Stanley Medical College, Chennai, India
E-mail Address: dr.arunkumarpillai@gmail.com
INTRODUCTION: Liver transplantation (LT) provides the only curative treatment
option for decompensated cirrhosis. The Model for End-Stage Liver Disease (MELD)
score is now used for allocation in LT waiting lists, replacing the Child-Turcotte-Pugh
(CTP) score. However, the optimal strategy based on scoring systems and/or waiting
time is still under debate.
AIMS & METHODS: Aim of the present was to compare the CTP scores and MELD
score for 3, 6months survival in cirrhotic patients waiting for liver transplant.
We investigated 216 consecutive patients listed for single-organ liver transplantation
for nonfulminant liver disease between April 2010 and June 2011. To assess the ability
of MELD and CTP score predicting the risk of death, the study was performed by
range by using c-statistic for area under the receiver operating characteristic curve.
RESULTS: 56 patients died during the observation period. The mean CTP score at
baseline, 3, 6 months was 7.4, 7.67 and 8.1 respectively for patients in the waiting
list 7.63, 8.9 and 9.48 for patients who died on waiting. The Mean MELD at 3, 6
months was 12.2, 13.37 and 16.99 respectively for patients in the waiting list and
14.8, 19.25 and 21.57 respectively for patients who died on waiting. The sensitivity
and specificity to identify mortality or severe deterioration for CTP was 83.9% and
89.5%, respectively; for MELD 88.6%, 91%, respectively. In stratified analysis there
were significant (<0.001) differences between them with low and intermediate range
MELD scores at 3 and no difference in 6 months.
CONCLUSION: MELD has a better performance over the CTP in determination of
priorities for organ allocation. Outcome with lower range MELD cannot be reliably
predicted only with their MELD scores, and alternative prognostic markers should
be used in conjunction to enhance the predictive accuracy. So, prognostic markers
like ascites and hyponatremia should be added with MELD to enhance the predictive
accuracy
REFERENCE(S): [1] Gotthardt D, Weiss KH, Baumgärtner M, Zahn A, Stremmel
W, Schmidt J, Bruckner T, Peter Sauer. Limitations of the MELD score in predicting
mortality or need for removal from waiting list in patients awaiting liver transplantation.
BMC Gastroenterology 2009, 9: 72. [2] Cholongitas E, Marelli L, Shusang V, Senzolo
M, Rolles K, Patch D, Burroughs AK. A systematic review of the performance of the
model for end-stage liver disease (MELD) in the setting of liver transplantation. Liver
Transpl. 2006 Jul; 12(7): 1049−61.
Disclosure of Interest: None Declared Gut 2012; 61 (Suppl 3) A108
P0018 IDIOPATHIC NON-CIRRHOTIC PORTAL HYPERTENSION: A
PROSPECTIVE LONG TERM FOLLOW-UP STUDY
A. Krishnan1, J. Venkataraman1. 1Department of Gastroenterology and Hepatology,
Stanley Medical College, Chennai, India
E-mail Address: dr.arunkumarpillai@gmail.com
INTRODUCTION: Cirrhosis is the most common cause of portal hypertension but
portal hypertension can also be present in the absence of cirrhosis, a condition referred
to as Idiopathic Non-Cirrhotic Portal Hypertension (INCPH). NCPH includes Extra
Hepatic Portal Vein Obstruction (EHPVO) and Non-Cirrhotic Portal Fibrosis (NCPF).
The natural history of INCPH is not clear.
AIMS & METHODS: Aim of the present was to determine prospectively the changes
in the portal venous system in patients with NCPH.
Patients with a diagnosis of NCPF and EHPVO registered since 2001 were serially
followed at an yearly interval for changes in liver size, its echotexture, and in the
intra and extrahepatic portal venous system. Baseline demographic details, LFT, and
co-morbid illness including virological profile were noted. Patients with co-morbid
illness and those with known etiology of cirrhosis were excluded from the study.
RESULTS: There were 34 patients with NCPF (M: F 1:1.8) and 30 patients with
EHPVO (M: F ratio 1.6:1). The mean age was 24.9 yrs and 41.2 yrs respectively.
During follow up, 20 out of 34 and 16 out of 30 patients with NCPF and EHPVO
respectively had no progression of disease. 14 patients with NCPF progressed to
cirrhosis over a mean period of 5.21 years. Eight patients developed ascites and
required diuretics. 14 patients with EHPVO progressed to NCPF over the mean period
of 8.6 years, 12 patients further progressed to cirrhosis over a mean period of 5.1 years.
Overall 40% of patients with EHPVO progressed to cirrhosis over a mean period of
13.7 years.
CONCLUSION: INCPH is a spectrum wherein EHPVO progresses to NCPF and
further to cirrhosis over a period of 13.7 years at least in a proportion of patients.
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P0019 SPLEEN STIFFNESS MEASUREMENT AS A NONINVASIVE
SUROGATE MARKER OF CLINICALLY SIGNIFICANT PORTAL
HYPERTENSION AND LARGE ESOPHAGEAL VARICES IN CIRRHOTIC
PATIENTS
H. Stefanescu1, B. Procopet1, M.-A. Robic2, M. Lupsor1, J.M. Peron2, C. Radu1,
R. Badea1, C. Bureau2. 13rd Medical Clinic, University of Medicine and Pharmacy,
Cluj-Napoca, Romania, 2Service d’Hepato Gastroenterologie, CHU Purpan, Toulouse,
France
E-mail Address: hstefanescu@umfcluj.ro
INTRODUCTION: Identification of novel noninvasive methods for liver cirrho-
sis(LC) assessment is one of the recommendations of the BavenoV meeting. Spleen
stiffness measurement(SSM) using Fibroscan was recently proposed as an estimate of
large esophageal varices(LEV) in cirrhotic patients.
AIMS & METHODS: The aim of this study was to validate SSM as a noninvasive
surrogate marker for LEV and clinically significant portal-hypertension(CSPH).
37 consecutive LC patients (training set − mean age 55.08 years, 68.3% males)
were included. All patients underwent HVPG measurement, endoscopy for esophageal
varices evaluation, common laboratory tests, liver and spleen stiffness measurements −
using the medium probe and the conventional calculation algorithm. The diagnostic
performance of SSM was evaluated using the AUROC method. The best cutoff values
of the 2 variables were used to estimate the presence of LEV in an independent
validation set of 118 cirrhotic patients (55.32 years, 61.8% males). The LEV estimation
according to SSM values was compared against endoscopy evaluation using the
interclass correlation coefficient.
RESULTS: In the training set, SSM correlated well with LSM, HVPG, and with the
presence of LEV and CSPH, as showed in the table.
LSM HVPG CSPH LEV
SSM r 0.676 0.774 0.692 0.640
p <0.0001 <0.0001 <0.0001 <0.0001
SSM mean values were significantly higher in patients with CSPH: 33.11 vs. 65.82kPa
(p< 0.0001). The same tendency was observed when LEVs were evaluated: 39.42 vs.
67.48kPa (p< 0.0001).
The AUROC for SSM predicting CSPH was 0.882 (Se=92.9%;Sp=84.2%).
The AUROC for predicting LEV was 0.845 for SSM (Se=100%;Sp=68%).
Interestingly, the cutoff value was the same (>42.7kPa) in predicting both CSPH and
LEV.
In the validation set, using the above-mentioned SSM cutoff values, we predicted the
presence of LEV with moderate accuracy [ICC only 0.402 (p = 0.003)].
CONCLUSION: SSM is a novel noninvasive parameter that correlates with the
presence of CSPH and LEV in cirrhotic patients, but it is not reliable enough to
be used alone for the assessment of LEV, so that endoscopy could be avoided
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P0020 CIRRHOTIC CARDIOMYOPATHY: DO WE NEED MORE THAN
BASELINE EVALUATION?
M. Barbosa1, J. Guardado2, B. Rosa1, C. Marinho1, I. Quelhas2, A. Lourenço2,
J. Cotter1. 1Gastroenterology, 2Cardiology, Alto Ave Hospital Center, Guimarães,
Portugal
E-mail Address: bruno.joel.rosa@gmail.com
INTRODUCTION: Cirrhotic cardiomyopathy (CC) is an important cause of morbidity
and mortality in patients with hepatic cirrhosis, especially when decompensated or
in those patients undergoing transjugular intrahepatic portosystemic shunt or hepatic
transplantation. In fact, although most cirrhotic patients have normal ventricular
function parameters in rest, they frequently reveal an attenuated systolic and diastolic
function under stress conditions.
AIMS & METHODS: We aimed to characterize a population of ambulatory cirrhotic
patients with determination of the prevalence of clinically silent CC. Patients with
hepatic cirrhosis, regardless of the etiology, were included and evaluated regarding
clinical, analytical, electrocardiographic and two-dimensional transthoracic doppler
echocardiography parameters, both at rest and after pharmacological stress with dobu-
tamine. Patients with cardiac or pulmonary major illness or those with cardiovascular
risk factors such as diabetes, hypertension or smoking habits were excluded from the
study. Diastolic and systolic echocardiographic features were obtained. Left ventricular
systolic function (LVSF) was evaluated through the determination of tele-diastolic
volume, tele-systolic volume and ejection fraction (EF), in rest and after low dose
dobutamine infusion. LVSF was considered insufficient when the EF increase after
dobutamine challenge was lower than 10%.
RESULTS: Twenty-six patients were included, 22 (85%) men, with mean age of
55±10 years. The hepatic cirrhosis was mainly of alcoholic etiology (76.9%) and
staged Child-Pugh A (n = 17), B (n = 8) and C (n = 1). Natriuretic brain peptide (pro-
BNP), an analytical marker of ventricular insufficiency or overload, had a mean value
of 110±111pg/ml. In 20 (76.9%) patients, the corrected QT (cQT) electrocardiographic
interval was prolonged (mean value 460±23mseg). All patients presented normal
baseline echocardiographic LFSV parameters (tele-diastolic volume 94±29.6ml, tele-
systolic volume 28±9.5ml, EF 69±8.1%). Nine (34.6%) patients presented with
diastolic dysfunction under resting conditions. After dobutamine challenge, 10 (38.5%)
patients had LVSF impairment, with an EF increase below the threshold of 10%.
CONCLUSION: In our series, a significant proportion (76.9%) of patients had a cQT
interval prolongation, and about a third had diastolic cardiac dysfunction. Moreover,
dobutamine stress echocardiography revealed a diminished cardiac reserve in more
